Massive Selection for Nicotinamide Mononucleotide Supplement Side Effects - RP-5264 Intermediate 6-fluoro-3-(3-fluorophenyl)-2-[(1R)-1-hydroxyethyl]-4H-1-Benzopyran-4-one – SyncoZymes
Massive Selection for Nicotinamide Mononucleotide Supplement Side Effects - RP-5264 Intermediate 6-fluoro-3-(3-fluorophenyl)-2-[(1R)-1-hydroxyethyl]-4H-1-Benzopyran-4-one – SyncoZymes Detail:
SyncoZymes (Shanghai) Co., Ltd. is the leading manufacturer and supplier of 6-fluoro-3-(3-fluorophenyl)-2-[(1R)-1-hydroxyethyl]-4H-1-Benzopyran-4-one (CAS: 1479107-10-2) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: lchen@syncozymes.com
Package: Bottle, Aluminum foil bag, 25kg/Cardboard Drum, or according to customer’s requirement.
Storage Condition:
6-fluoro-3-(3-fluorophenyl)-2-[(1R)-1-hydroxyethyl]-4H-1-Benzopyran-4-one (CAS: 1479107-10-2) is a useful sythetic intermediate, used as pharmaceutical intermediates.
Product detail pictures:
Related Product Guide:
With our leading technology as well as our spirit of innovation,mutual cooperation, benefits and development, we will build a prosperous future together with your esteemed company for Massive Selection for Nicotinamide Mononucleotide Supplement Side Effects - RP-5264 Intermediate 6-fluoro-3-(3-fluorophenyl)-2-[(1R)-1-hydroxyethyl]-4H-1-Benzopyran-4-one – SyncoZymes , The product will supply to all over the world, such as: South Africa, India, USA, Our technical expertise, customer-friendly service, and specialized products make us/company name the first choice of customers and vendors. We are looking for your inquiry. Let's set up the cooperation right now!
By Nicole from Southampton - 2018.11.28 16:25
We have been engaged in this industry for many years, we appreciate the work attitude and production capacity of the company, this is a reputable and professional manufacturer.
By Hulda from Stuttgart - 2017.11.11 11:41
Write your message here and send it to us